Literature DB >> 8200573

Spontaneous bacterial peritonitis in cystic fibrosis.

C F Doershuk1, R C Stern.   

Abstract

Bacterial peritonitis presents with classic symptoms of fever and abdominal pain. Some patients, however, are completely asymptomatic. Death in the short term is considerable, especially in patients with alcoholic cirrhosis. Cystic fibrosis patients occasionally develop biliary cirrhosis and may have secondary hypersplenism, varices, and ascites. These patients should be at risk for spontaneous bacterial peritonitis. Spontaneous bacterial peritonitis is described in two patients with longstanding hepatic cirrhosis secondary to cystic fibrosis. Both had required splenectomy for complications of portal hypertension. This is a previously unreported, but potentially fatal, complication of cystic fibrosis liver disease. Early diagnostic paracentesis is essential so that appropriate acute management, including antimicrobial treatment can be started. In the long term, these patients deserve immediate paracentesis for any evidence of recurrence. Whether the patient is treated with chronic (continuous) antimicrobial prophylaxis or only receives antimicrobial treatment during periods when bacteraemia is possible (for example, dental work, bronchoscopy), it would seem reasonable in patients with cystic fibrosis to use a wide spectrum antimicrobial agent with activity against Pseudomonas aeruginosa, other common Gram negative organisms, and Staphylococcus aureus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200573      PMCID: PMC1374764          DOI: 10.1136/gut.35.5.709

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  INFECTION OF ASCITIC FLUID IN PATIENTS WITH HEPATIC CIRRHOSIS.

Authors:  D N KERR; D T PEARSON; A E READ
Journal:  Gut       Date:  1963-12       Impact factor: 23.059

2.  Spontaneous bacterial peritonitis in cirrhosis: variations on a theme.

Authors:  H O Conn; J M Fessel
Journal:  Medicine (Baltimore)       Date:  1971-05       Impact factor: 1.889

3.  Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients.

Authors:  G Pinzello; R G Simonetti; A Craxì; S Di Piazza; C Spanò; L Pagliaro
Journal:  Hepatology       Date:  1983 Jul-Aug       Impact factor: 17.425

4.  Symptomatic hepatic disease in cystic fibrosis: incidence, course, and outcome of portal systemic hunting.

Authors:  R C Stern; D P Stevens; T F Boat; C F Doershuk; R J Izant; L W Matthews
Journal:  Gastroenterology       Date:  1976-05       Impact factor: 22.682

5.  Spontaneous bacterial peritonitis.

Authors:  J C Hoefs; H N Canawati; F L Sapico; R R Hopkins; J Weiner; J Z Montgomerie
Journal:  Hepatology       Date:  1982 Jul-Aug       Impact factor: 17.425

6.  Inoculation of blood culture bottles with ascitic fluid. Improved detection of spontaneous bacterial peritonitis.

Authors:  B A Runyon; E T Umland; T Merlin
Journal:  Arch Intern Med       Date:  1987-01

7.  Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis.

Authors:  B A Runyon; J C Hoefs
Journal:  Hepatology       Date:  1984 Nov-Dec       Impact factor: 17.425

8.  Cystic fibrosis: a new outlook. 70 patients above 25 years of age.

Authors:  H Shwachman; M Kowalski; K T Khaw
Journal:  Medicine (Baltimore)       Date:  1977-03       Impact factor: 1.889

9.  Diuresis of cirrhotic ascites increases its opsonic activity and may help prevent spontaneous bacterial peritonitis.

Authors:  B A Runyon; D E Van Epps
Journal:  Hepatology       Date:  1986 May-Jun       Impact factor: 17.425

10.  The pH of ascitic fluid in the diagnosis of spontaneous bacterial peritonitis in alcoholic cirrhosis.

Authors:  N Gitlin; J L Stauffer; R C Silvestri
Journal:  Hepatology       Date:  1982 Jul-Aug       Impact factor: 17.425

View more
  1 in total

Review 1.  Abdominal pain in cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.